default author photo

Caddie D. Laberiano Fernandez

University of Texas at Houston - Department of Translational Molecular Pathology

SCHOLARLY PAPERS

1

DOWNLOADS

49

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Phase II Trial of Pembrolizumab in Combination with Chemotherapy for Frontline Treatment of Advanced Epithelial Ovarian Cancer

Number of pages: 44 Posted: 28 Mar 2024
University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, Texas Oncology, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, Texas Oncology, University of Texas at Houston - Department of Genomic Medicine and University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine
Downloads 49 (1,074,648)

Abstract:

Loading...

pembrolizumab, combination chemotherapy, ovarian cancer, immunotherapy, tumor immune microenvironment, translational, clinical trial, feasibility